Clascoterone and its Impurities

Clascoterone, sold under the brand name Winlevi, is an antiandrogen medication which is used topically in the treatment of acne. Reference standards of Clascoterone API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 5 results for Clascoterone Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 03 4420000

Clascoterone

Clascoterone


  • Catalogue No.:PA 03 4420000

  • CAS :

    19608-29-8

  • Molecular Formula : C24H34O5

  • Molecular Weight : 402.53

Drug Reference Standards & Impurity Synthesis in India
PA 03 4421000

(8R,9S,10R,13S,14S,17R)-2'-Ethoxy-2'-ethyl-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-17,4'-[1,3]dioxane]-3,5'(2H)-dione

(8R,9S,10R,13S,14S,17R)-2'-Ethoxy-2'-ethyl-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-17,4'-[1,3]dioxane]-3,5'(2H)-dione


  • Catalogue No.:PA 03 4421000

  • CAS :

    85198-30-7

  • Molecular Formula : C26H38O5

  • Molecular Weight : 430.59

Drug Reference Standards & Impurity Synthesis in India
PA 03 4421001

(8R,9S,10R,13S,14S,17R)-17-(2-Hydroxyacetyl)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate

(8R,9S,10R,13S,14S,17R)-17-(2-Hydroxyacetyl)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate


  • Catalogue No.:PA 03 4421001

  • CAS :

    NA

  • Molecular Formula : C24H32O5

  • Molecular Weight : 400.52

Drug Reference Standards & Impurity Synthesis in India
PA STI 089692

Clascoterone D6

Clascoterone D6


  • Catalogue No.:PA STI 089692

  • CAS :

    NA

  • Molecular Formula : C24H29D5O5

  • Molecular Weight : 407.56

Drug Reference Standards & Impurity Synthesis in India
PA BSC 44203650

Clascoterone (BSC)

Clascoterone


  • Catalogue No.:PA BSC 44203650

  • CAS :

    19608-29-8

  • Molecular Formula : C24H34O5

  • Molecular Weight : 402.53

pharmaffiliates